Zobrazeno 1 - 10
of 14
pro vyhledávání: '"John P Wilding"'
Autor:
Matthew Anson, Alex E. Henney, Nicholas Broadwell, Sizheng S. Zhao, Gema H. Ibarburu, Gregory Y.H. Lip, John P.H. Wilding, Daniel J. Cuthbertson, Uazman Alam
Publikováno v:
EClinicalMedicine, Vol 75, Iss , Pp 102777- (2024)
Summary: Background: Tirzepatide, a novel dual agonist of glucagon-like-peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), has demonstrated greater magnitude of weight loss compared to semaglutide in a phase 3 clinical trial. H
Externí odkaz:
https://doaj.org/article/93b14b0a5d844a77bc3a8c1845bb3ae3
Autor:
John D. Wilding, Zachary E. Ross
Publikováno v:
Volcanica, Vol 7, Iss 1, Pp 1-19 (2024)
Magma supply rates from the mantle to Hawaiian volcanoes serve as an important control on eruptive behavior at the surface. The Pa ̄hala Sill Complex, a collection of magma-bearing, seismogenic structures at 40 km depth beneath Hawai‘i, presents a
Externí odkaz:
https://doaj.org/article/3bafb01b73b54d1e8966fe7dffee299e
Autor:
Emily Brown, Andrew Williams, Olah Hakim, Moon M. Wilton, Joanne A. Harrold, David Hughes, Graham J. Kemp, John P.H. Wilding, Louise M. Goff, Daniel J. Cuthbertson
Publikováno v:
JCSM Rapid Communications, Vol 5, Iss 2, Pp 149-153 (2022)
Abstract Background Sarcopenia is an age‐related loss of skeletal muscle mass (SMM) and function, associated with falls, frailty, and functional decline. It is more prevalent and often accelerated in people with Type 2 diabetes (T2D), especially wh
Externí odkaz:
https://doaj.org/article/22310836c3ba43a3acf62725c5cced4d
Autor:
Emily Brown, Victoria S Sprung, Graham J Kemp, John PH Wilding, Malcolm Burgess, Daniel J Cuthbertson, A Margot Umpleby, Jason C G Halford, Andrej Stancak, Moon M Wilton, Joanne A Harrold, Elaine Howarth
Publikováno v:
BMJ Open, Vol 11, Iss 7 (2021)
Introduction The newer glucose-lowering therapies for type 2 diabetes (T2D), the glucagon-like peptide-1 receptor agonists (GLP1-RAs) and the sodium-glucose co-transporter 2 inhibitors (SGLT2i), have additional clinical benefits beyond improving glyc
Externí odkaz:
https://doaj.org/article/e58426e12bf4422080cccd3ed1011943
Autor:
Victoria S Sprung, Graham J Kemp, John PH Wilding, Valerie Adams, Kieran Murphy, Malcolm Burgess, Stephen Emegbo, Matthew Thomas, Alexander J Needham, Andrew Weimken, Richard J Schwab, Ari Manuel, Sonya E Craig, Daniel J Cuthbertson
Publikováno v:
BMJ Open, Vol 10, Iss 7 (2020)
Introduction Obstructive sleep apnoea (OSA) and type 2 diabetes mellitus (T2DM) often occur concurrently, and untreated OSA may potentially amplify the high risk of cardiovascular disease in T2DM. Compliance with continuous positive airway pressure (
Externí odkaz:
https://doaj.org/article/81600400deda44a58b7e80246290a587
Autor:
Ian W Seetho, Adela Ramírez-Torres, Amaya Albalat, William Mullen, Harald Mischak, Robert J Parker, Sonya Craig, Nick Duffy, Kevin J Hardy, Jatin G Burniston, John PH Wilding
Publikováno v:
Sleep Science, Vol 8, Iss 2, Pp 58-67 (2015)
Introduction: Obstructive sleep apnoea (OSA) is common in obesity and is associated with cardiovascular and metabolic complications. Continuous positive airway pressure (CPAP) in OSA may lead to physiological changes reflected in the urinary proteome
Externí odkaz:
https://doaj.org/article/6a43a7c325a146419e56822396467fb1
Autor:
Shun Kohsaka, Carolyn S P Lam, Dae Jung Kim, Matthew A Cavender, Anna Norhammar, Marit E Jørgensen, Kåre I Birkeland, Reinhard W Holl, Josep Franch-Nadal, Navdeep Tangri, Jonathan E Shaw, Jenni Ilomäki, Avraham Karasik, Su-Yen Goh, Chern-En Chiang, Marcus Thuresson, Hungta Chen, Eric Wittbrodt, Johan Bodegård, Filip Surmont, Peter Fenici, Mikhail Kosiborod, John P Wilding, Kamlesh Khunti, Kåre Birkeland, Marit Eika Jørgensen, Reinhard W. Holl, Carolyn SP Lam, Hanne Løvdal Gulseth, Bendix Carstensen, Esther Bollow, Luis Alberto García Rodríguez, Jonathan Shaw, Suzanne Arnold, Betina T. Blak, Eric T. Wittbrodt, Matthias Saathoff, Yusuke Noguchi, Donna Tan, Maro Williams, Hye Won Lee, Maya Greenbloom, Oksana Kaidanovich-Beilin, Khung Keong Yeo, Yong Mong Bee, Joan Khoo, Agnes Koong, Yee How Lau, Fei Gao, Wee Boon Tan, Hanis Abdul Kadir, Kyoung Hwa Ha, Jinhee Lee, Gabriel Chodick, Cheli Melzer-Cohen, Reid Whitlock, Lucia Cea-Soriano, Oscar Fernándex Cantero, Jordan A. Menzin, Matthew Guthrie, Jennie Ilomaki, Dianna Magliano
Publikováno v:
Kohsaka, S, Lam, C S P, Kim, D J, Cavender, M A, Norhammar, A, Jørgensen, M E, Birkeland, K, Holl, R W, Franch-Nadal, J, Tangri, N, Shaw, J, Ilomäki, J, Karasik, A, Goh, S Y, Chiang, C E, Thuresson, M, Chen, H, Wittbrodt, E, Bodegård, J, Surmont, F, Fenici, P & Kosiborod, M 2020, ' Risk of cardiovascular events and death associated with initiation of SGLT2 inhibitors compared with DPP-4 inhibitors : an analysis from the CVD-REAL 2 multinational cohort study ', The Lancet Diabetes and Endocrinology, vol. 8, no. 7, pp. 606-615 . https://doi.org/10.1016/S2213-8587(20)30130-3
Lancet Diabetes & Endocrinology, 8(7), 606-615. ELSEVIER SCIENCE INC
Lancet Diabetes & Endocrinology, 8(7), 606-615. ELSEVIER SCIENCE INC
Background: Cardiovascular outcome trials have shown cardiovascular benefit with sodium-glucose co-transporter-2 (SGLT2) inhibitors in patients with type 2 diabetes, whereas dipeptidyl peptidase-4 (DPP-4) inhibitors have not shown an effect. We aimed
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::68860c6556bbf38e0e25d66268d78e6f
https://doi.org/10.1016/s2213-8587(20)30130-3
https://doi.org/10.1016/s2213-8587(20)30130-3
Autor:
Scarla Weeks, P. Jeremy Werdell, Britta Schaffelke, Marites Canto, Zhongping Lee, John G. Wilding, Gene C. Feldman
Publikováno v:
Remote Sensing, Vol 4, Iss 12, Pp 3781-3795 (2012)
Detecting changes to the transparency of the water column is critical for understanding the responses of marine organisms, such as corals, to light availability. Long-term patterns in water transparency determine geographical and depth distributions,
Externí odkaz:
https://doaj.org/article/2534ccaa61984855b4768c99bd0b6dcb
Autor:
John P. Wilding, Jonathan Z.M. Lim
Lifestyle interventions that restrict energy intake, increase physical activity, and modify behaviour are the mainstay of most weight management programmes. Diets producing an intake of 500–600 kcal day below estimated total daily energy expenditur
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b7d3b67503af70f9054a25ba6ab30a83
https://doi.org/10.1093/med/9780198870197.003.0225
https://doi.org/10.1093/med/9780198870197.003.0225
Autor:
Mikhail Kosiborod, Carolyn S.P. Lam, Shun Kohsaka, Dae Jung Kim, Avraham Karasik, Jonathan Shaw, Navdeep Tangri, Su-Yen Goh, Marcus Thuresson, Hungta Chen, Filip Surmont, Niklas Hammar, Peter Fenici, Matthew A. Cavender, Alex Z. Fu, John P. Wilding, Kamlesh Khunti, Anna Norhammar, Kåre Birkeland, Marit Eika Jørgensen, Reinhard W. Holl, Carolyn SP Lam, Hanne Løvdal Gulseth, Bendix Carstensen, Esther Bollow, Josep Franch-Nadal, Luis Alberto García Rodríguez, Suzanne Arnold, Johan Bodegård, Kyle Nahrebne, Betina T. Blak, Eric T. Wittbrodt, Matthias Saathoff, Yusuke Noguchi, Donna Tan, Maro Williams, Hye Won Lee, Maya Greenbloom, Oksana Kaidanovich-Beilin, Khung Keong Yeo, Yong Mong Bee, Joan Khoo, Agnes Koong, Yee How Lau, Fei Gao, Wee Boon Tan, Hanis Abdul Kadir, Kyoung Hwa Ha, Jinhee Lee, Gabriel Chodick, Cheli Melzer Cohen, Reid Whitlock, Lucia Cea Soriano, Oscar Fernándex Cantero, Ellen Riehle, Jennie Ilomaki, Dianna Magliano
Publikováno v:
Journal of the American College of Cardiology. 71:2628-2639
Background Randomized trials demonstrated a lower risk of cardiovascular (CV) events with sodium-glucose cotransporter-2 inhibitors (SGLT-2i) in patients with type 2 diabetes (T2D) at high...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c038c980a989a7310ab5eda77779b972
https://doi.org/10.1016/j.jacc.2018.03.009
https://doi.org/10.1016/j.jacc.2018.03.009